InMed Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of June 2026: 1.31%

InMed Pharmaceuticals Inc (INM) has an Asset Resilience Ratio of 1.31% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See InMed Pharmaceuticals Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$39.67 Million

Cash + Short-term Investments

Total Assets

$3.03 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2026)

This chart shows how InMed Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of InMed Pharmaceuticals Inc.

Liquid Assets Composition Over Time

This chart breaks down InMed Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read InMed Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$39.67 Million	1.31%
Total Liquid Assets	$39.67 Million	1.31%

Asset Resilience Insights

Limited Liquidity: InMed Pharmaceuticals Inc maintains only 1.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

InMed Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare InMed Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for InMed Pharmaceuticals Inc (2001–2026)

The table below shows the annual Asset Resilience Ratio data for InMed Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-06-30	1.31%	$39.67 Million	$3.03 Billion	+1.10pp
2025-06-30	0.21%	$43.56K	$21.23 Million	-0.15pp
2022-06-30	0.35%	$57.69K	$16.46 Million	-0.12pp
2021-06-30	0.48%	$57.46K	$12.10 Million	-0.07pp
2020-06-30	0.54%	$42.38K	$7.80 Million	-25.56pp
2019-06-30	26.10%	$3.93 Million	$15.07 Million	+17.75pp
2018-06-30	8.35%	$1.78 Million	$21.34 Million	+5.59pp
2003-06-30	2.75%	$32.04K	$1.16 Million	-45.03pp
2002-06-30	47.78%	$651.24K	$1.36 Million	+1.80pp
2001-06-30	45.98%	$2.15 Million	$4.67 Million	--

pp = percentage points

About InMed Pharmaceuticals Inc

NASDAQ:INM USA Drug Manufacturers - Specialty & Generic

Market Cap

$6.83 Million

Market Cap Rank

#28042 Global

#5765 in USA

Share Price

$1.28

Change (1 day)

-1.54%

52-Week Range

$0.62 - $2.46

All Time High

$31185.00